What it sells
The world's first digital clinic for substance use management
Business model breakdown
Buyer: who owns the budget?
Employers (benefits/HR) and health plans/PBMs, per the Organizations menu.
Trigger: what makes them buy now?
UnverifiedRising medical spend from untreated substance use and low engagement with generic EAPs.
Workflow: what inputs become what output?
Member enrolls privately, AI-led access (Sona) routes to the right level of care with clinicians for moderate and complex needs, tracked in the Atlas clinical record.
Economics: what it saves and how it charges
Outcomes-based contracts with fees at risk; claims ROI in year one and medical cost savings per participant; says untreated substance use inflates large medical claims.
Distribution: how it reaches customers
Demo-led to employers and health plans; members enroll through employer coverage ('Am I eligible?').
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2018 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.